Cutler Group’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-49,500
| Closed | -$4.2M | – | 5040 |
|
|
2019
Q4 | $4.2M | Sell |
49,500
-38,808
| -44% | -$2.59M | 0.26% | 58 |
|
|
2019
Q3 | $4.42M | Buy |
88,308
+30,300
| +52% | +$1.21M | 0.4% | 28 |
|
|
2019
Q2 | $2.12M | Buy |
58,008
+7,608
| +15% | +$248K | 0.2% | 83 |
|
|
2019
Q1 | $1.41M | Buy |
50,400
+50,161
| +20,988% | +$1.18M | 0.15% | 128 |
|
|
2018
Q4 | $4K | Sell |
239
-150
| -39% | -$3.49K | ﹤0.01% | 3106 |
|
|
2018
Q3 | $11K | Sell |
389
-200
| -34% | -$7.54K | ﹤0.01% | 2627 |
|
|
2018
Q2 | $21K | Sell |
589
-4,009
| -87% | -$130K | ﹤0.01% | 2176 |
|
|
2018
Q1 | $151K | Sell |
4,598
-15,554
| -77% | -$486K | 0.01% | 955 |
|
|
2017
Q4 | $550K | Sell |
20,152
-16,669
| -45% | -$513K | 0.02% | 513 |
|
|
2017
Q3 | $1.36M | Sell |
36,821
-6,596
| -15% | -$243K | 0.05% | 273 |
|
|
2017
Q2 | $1.65M | Sell |
43,417
-18,245
| -30% | -$813K | 0.06% | 264 |
|
|
2017
Q1 | $3.02M | Buy |
61,662
+24,284
| +65% | +$1.11M | 0.13% | 141 |
|
|
2016
Q4 | $1.27M | Sell |
37,378
-2,089
| -5% | -$74.1K | 0.05% | 331 |
|
|
2016
Q3 | $1.49M | Buy |
39,467
+6,286
| +19% | +$237K | 0.07% | 213 |
|
|
2016
Q2 | $1.11M | Buy |
33,181
+3,519
| +12% | +$124K | 0.06% | 268 |
|
|
2016
Q1 | $942K | Sell |
29,662
-46,176
| -61% | -$1.51M | 0.06% | 282 |
|
|
2015
Q4 | $2.83M | Buy |
+75,838
| New | +$2.87M | 0.16% | 104 |
|
Other funds holding MDCO
Cutler Group's MDCO Position: Q1 2020 in Review
Cutler Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 49,500 shares — an estimated $4.2M sold.
Cutler Group first reported a position in MDCO in Q4 2015 and held it in 17 quarters. The position peaked at $4.42M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Cutler Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Cutler Group sold 49,500 Medicines Co shares in Q1 2020, an estimated $4.2M.
- Cutler Group first reported a position in Medicines Co in Q4 2015 and held it in 17 quarters.
- Cutler Group's Medicines Co position peaked at $4.42M in Q3 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Cutler Group's 13F filing for Q1 2020, filed 7 May 2020.